Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
International Journal of Data Mining and Bioinformatics|August 29, 2014
A novel strategy for molecular signature discovery based on independent component analysisHang-Phuong Pham, Nicolas Dérian, Wahiba Chaara, et al.Microbiome|August 4, 2019
Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and hostAonghus Lavelle, Thomas Walter Hoffmann, Hang-Phuong Pham, et al.Plos One|April 21, 2022
The Tsallis generalized entropy enhances the interpretation of transcriptomics datasetsNicolas Dérian, Hang-Phuong Pham, Djamel Nehar-Belaid, et al.European Journal of Immunology|November 23, 2011
Half of the T-cell repertoire combinatorial diversity is genetically determined in humans and humanized miceHang-Phuong Pham, Manuarii Manuel, Nicolas Petit, et al.Skeletal Radiology|November 15, 2011
Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastasesFrédéric Clarençon, Betty Jean, Hang-Phuong Pham, et al.Plos Computational Biology|March 22, 2016
Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell ResponsesNicolas Dérian, Bertrand Bellier, Hang Phuong Pham, et al.Plos One|February 5, 2016
A TCRβ Repertoire Signature Can Predict Experimental Cerebral MalariaEncarnita Mariotti-Ferrandiz, Hang-Phuong Pham, Sophie Dulauroy, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2022
Clonotypic IgH Response against Systemic Viral infection in Pronephros and Spleen of a Teleost FishRosario Castro, Susana Magadán, Luc Jouneau, et al.Frontiers in Immunology|December 19, 2013
The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysisAdrien Six, Maria Encarnita Mariotti-Ferrandiz, Wahiba Chaara, et al.Annals of the Rheumatic Diseases|August 16, 2022
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trialJens Y Humrich, Patrice Cacoub, Michelle Rosenzwajg, et al.Pageof 4